stock · yahoo

Elevance Health, Inc.

ELV

$409.44
18.17 (4.64%)
polled · warming up

Aşağıda Elevance Health, Inc. (ELV) için canlı hisse fiyatı, 1 yıllık grafik, 8 indikatör (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Hacim) ve karşılaştırma modu var. Portföyüne ekleyebilir, izleme listene yıldız atabilir veya fiyat alarmı kurabilirsin.

Day
+4.64%
+18.17
Week
+4.25%
+16.69
Month
+10.94%
+40.37
Year
Prev close
$391.27
Volume
$1.07M
Market cap
$88.91B
Currency
USD

Financials

52w high
$411.80
52w low
$273.71
52w change
1.72%
Day high
$411.80
Day low
$397.43
P/E (TTM)
17.36
Forward P/E
14
PEG
1.42
Price / Book
2.03
Beta (5Y)
0.67
Enterprise value
83.82B
EV / Revenue
0.42
EV / EBITDA
9.81
EPS (TTM)
$23.58
Forward EPS
$29.25
Dividend yield
1.68%
Dividend rate
$6.88
Payout ratio
29.03%
Revenue (TTM)
200.42B
EBITDA
8.54B
Free cash flow
4.3B
Total cash
37.07B
Total debt
31.84B
Debt / Equity
72.3
Current ratio
1.48
Quick ratio
1.33
Profit margin
2.62%
Gross margin
25.89%
Return on assets
3.98%
Return on equity
12.09%
Shares outstanding
217.16M
Float
216.71M
Sector: HealthcareIndustry: Healthcare PlansHQ: United StatesEmployees: 96.13Kwww.elevancehealth.com

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Analyst & Risk

Consensus
Buy
Mean rating1.77 / 5
Analysts21
Next earnings2026-07-16
Strong buy 3Buy 12Hold 7
Analyst price target
$407.62
Mean target · 21 analysts
-0.4%
upside
Low $331.00Now $409.44High $498.00
Beta (vs S&P 500)
0.67
less volatile
52-week change
1.72%
Short % of float
3.14%
Short ratio (days)
3.34
Debt / Equity
72.3
very high leverage
Current ratio
1.48
Quick ratio
1.33
ROE
12.09%
ROA
3.98%
PEG ratio
1.42
fair
EV / Revenue
0.42
EV / EBITDA
9.81
Revenue growth
2.60%
Earnings growth
-16.80%
EBITDA
8.54B
Free cash flow
4.3B
Total cash
37.07B
Total debt
31.84B
Insider holdings
0.19%
Institutional
93.45%

Recent rating changes

  • 2026-06-04B of A SecuritiesBuyBuymain
  • 2026-06-04Morgan StanleyEqual-WeightEqual-Weightmain
  • 2026-06-01Truist SecuritiesBuyBuymain
  • 2026-05-26BarclaysOverweightOverweightmain
  • 2026-05-22UBSBuyBuymain
  • 2026-05-20MizuhoOutperformOutperformmain
  • 2026-05-20Deutsche BankHoldBuyup
  • 2026-04-29B of A SecuritiesNeutralBuyup

Canlı tartışma

Giriş to join the discussion.

  • Henüz yorum yok. İlk siz olun.